-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 14, Kexing Pharmaceuticals announced that it received the “Approval Notice for Supplementary Drug Application” approved and issued by the State Food and Drug Administration on February 12.
In the treatment of "anemia caused by chemotherapy of non-myeloid malignant tumors", large-scale human erythropoietin products can significantly reduce the frequency of medication, and improve the patient's medication compliance under the premise of equal efficacy